BRPI0403668A - composições farmacêuticas de desintegração oral com altas concentrações de aspartame - Google Patents

composições farmacêuticas de desintegração oral com altas concentrações de aspartame

Info

Publication number
BRPI0403668A
BRPI0403668A BRPI0403668A BRPI0403668A BR PI0403668 A BRPI0403668 A BR PI0403668A BR PI0403668 A BRPI0403668 A BR PI0403668A BR PI0403668 A BRPI0403668 A BR PI0403668A
Authority
BR
Brazil
Prior art keywords
aspartame
pharmaceutical compositions
oral disintegrating
agents
high concentrations
Prior art date
Application number
Other languages
English (en)
Inventor
Dante Junior Alario
Original Assignee
Biolab Sanus Farmaceutica Ltda
Univ Sao Paulo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37770440&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0403668(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmaceutica Ltda, Univ Sao Paulo filed Critical Biolab Sanus Farmaceutica Ltda
Priority to BRPI0403668A priority Critical patent/BRPI0403668B8/pt
Publication of BRPI0403668A publication Critical patent/BRPI0403668A/pt
Publication of BRPI0403668B1 publication Critical patent/BRPI0403668B1/pt
Publication of BRPI0403668B8 publication Critical patent/BRPI0403668B8/pt

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS DE DESINTEGRAçãO ORAL COM ALTAS CONCENTRAçõES DE ASPARTAME". A presente invenção consiste de comprimidos de desintegração oral caracterizados por conterem: (i) de 0, 01 a 15 % de um ou mais ingredientes ativos; (ii) de 10 a 30% de aspartame; (iii) de 20 a 50% de um ou mais agentes superdesintegrantes; (iv) de 20 a 50 % de um ou mais agentes para compressão hidrossolúveis; (v) de 5 a 15% de um agente para compressão celulósico; (vi) opcionalmente, um ou mais excipientes selecionados do grupo composto por: flavorizantes, corantes, glidantes, lubrificantes, materiais de revestimento, agentes efervescentes, tensoativos, ou misturas destes.
BRPI0403668A 2004-09-01 2004-09-01 composições farmacêuticas de desintegração oral com altas concentrações de aspartame BRPI0403668B8 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0403668A BRPI0403668B8 (pt) 2004-09-01 2004-09-01 composições farmacêuticas de desintegração oral com altas concentrações de aspartame

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0403668A BRPI0403668B8 (pt) 2004-09-01 2004-09-01 composições farmacêuticas de desintegração oral com altas concentrações de aspartame

Publications (3)

Publication Number Publication Date
BRPI0403668A true BRPI0403668A (pt) 2007-02-27
BRPI0403668B1 BRPI0403668B1 (pt) 2018-03-13
BRPI0403668B8 BRPI0403668B8 (pt) 2021-05-25

Family

ID=37770440

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0403668A BRPI0403668B8 (pt) 2004-09-01 2004-09-01 composições farmacêuticas de desintegração oral com altas concentrações de aspartame

Country Status (1)

Country Link
BR (1) BRPI0403668B8 (pt)

Also Published As

Publication number Publication date
BRPI0403668B8 (pt) 2021-05-25
BRPI0403668B1 (pt) 2018-03-13

Similar Documents

Publication Publication Date Title
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
MY143795A (en) Tetrahydropyridoindole derivatives
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
ATE355829T1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
DE602005025755D1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
CA2322315A1 (en) Fast disintegrating tablets
BRPI0410116A (pt) tablete de cuidado oral
TW200633978A (en) 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists
MX2009003030A (es) Forma galenita para la administracion por via transmucosa de principios activos.
MY141243A (en) Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
HUP0401811A2 (hu) Javított vízoldékonyságú gyógyszerkészítmény és eljárás az előállítására
AR070593A1 (es) Composiciones efervescentes
BR0117147A (pt) preparado de dosagem oral de desintegração instantánea
MXPA04003506A (es) Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
WO2003028624A3 (en) Levothyroxine compositions and methods
BRPI0403668A (pt) composições farmacêuticas de desintegração oral com altas concentrações de aspartame
US20070286834A1 (en) Water stream dispersible skin care solid composition
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
WO2004014318A3 (en) Levothyroxine compositions and methods
WO2003013441A3 (en) Levothyroxine compositions and methods

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B03H Publication of an application: rectification [chapter 3.8 patent gazette]

Free format text: REFERENTE A RPI 1886 DE 27/02/2007, QUANTO AO ITEM (72)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted
B17A Notification of administrative nullity (patentee has 60 days time to reply to this notification)

Free format text: REQUERENTE DA NULIDADE: HYPERA S.A - PETICAO NO870180129609 DE 12/09/2018.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/09/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF